Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer

被引:18
|
作者
Lin, Kimberly C. [1 ,2 ]
Park, Hyun Woo [3 ]
Guan, Kun-Liang [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[3] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
Hippo pathway; cancer; YAP; NF2; immunotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; YES-ASSOCIATED PROTEIN; REGULATES CELL-PROLIFERATION; TEAD TRANSCRIPTION FACTORS; AMPK-MEDIATED REGULATION; YAP PATHWAY; SIGNALING-PATHWAY; TUMOR-SUPPRESSOR; CONTACT INHIBITION; UVEAL MELANOMA;
D O I
10.1146/annurev-cancerbio-030617-050202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Hippo pathway has drawn increasing interest in the past decade for its role in the regulation of cell growth, differentiation, organ size, and tissue homeostasis. Recent studies have expanded our knowledge of known upstream regulators of the Hippo pathway and have consistently demonstrated that the Hippo pathway is critical for translating cellular cues into transcriptional responses by receiving input from a wide range of upstream signals. Dramatic overgrowth phenotypes upon deregulation of the Hippo pathway have prompted investigation into its role in cancer. Here we provide an overview of the Hippo pathway, our current understanding of its role in tumorigenesis, and potential therapeutics targeting Hippo signaling.
引用
收藏
页码:59 / 79
页数:21
相关论文
共 50 条
  • [1] Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
    Mohajan, Suman
    Jaiswal, Praveen Kumar
    Vatanmakarian, Mousa
    Yousefi, Hassan
    Sankaralingam, Saikolappan
    Alahari, Suresh K.
    Koul, Sweaty
    Koul, Hari K.
    CANCER LETTERS, 2021, 507 : 112 - 123
  • [2] The Hippo pathway in endometrial cancer: a potential therapeutic target?
    Shen, Xinyun
    Li, Qianqian
    Sun, Yiqing
    Chen, Lingli
    Xue, Fengxia
    Tian, Wenyan
    Wang, Yingmei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential
    Arora, Taruna
    Kausar, Mohd Adnan
    Aboelnaga, Shimaa Mohammed
    Anwar, Sadaf
    Hussain, Malik Asif
    Sadaf, Sadaf
    Kaur, Simran
    Eisa, Alaa Abdulaziz
    Shingatgeri, Vyas Murti Madhavrao
    Najm, Mohammad Zeeshan
    Aloliqi, Abdulaziz A.
    ONCOLOGY REPORTS, 2022, 48 (01)
  • [4] Hippo pathway deregulation in cancers
    Dey, Anwesha
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [5] Deregulated Hippo pathway is a potential therapeutic target for advanced gallbladder cancer
    Bizama, Carolina
    Garcia, Patricia
    Espinoza, Jaime A.
    Elgueta, Nicole
    Riquelme, Ismael
    Alfaro, Francisca
    Romero, Diego
    Weber, Helga
    Leal, Pamela
    Retamal, Javier
    Rosa, Lorena
    Roa, Juan Carlos
    CANCER RESEARCH, 2016, 76
  • [6] Deregulation of the Hippo Signaling Pathway in Virus-Associated Cancer
    Behboudi, Emad
    Hashemzadeh, Mohammad S.
    Ramezani, Ali
    Jari, Ali
    Ebrahimi, Negar
    Ghasemi, Somayeh
    Makvandi, Manoocher
    Gholamzadeh, Tahereh
    Faghihloo, Ebrahim
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2023, 126 (02) : 172 - 184
  • [7] Hippo pathway deregulation in cancers.
    Dey, Anwesha
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 16 - 16
  • [8] Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential
    Mohammadpour, Somayeh
    Esfahani, Amir Torshizi
    Sarpash, SeyedKasra
    Vakili, Fatemeh
    Zafarjafarzadeh, Nikta
    Mashaollahi, Amirhesam
    Pardakhtchi, Ali
    Nazemalhosseini-Mojarad, Ehsan
    ANALYTICAL CELLULAR PATHOLOGY, 2024, 2024
  • [9] Systematic pan-cancer analyses of Hippo pathway deregulation in cancer.
    Chang, Matthew T.
    Hagenbeek, Thijs J.
    Lacap, Jennifer
    Modrusan, Zora
    Klijn, Christiaan
    Dey, Anwesha
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 23 - 23
  • [10] Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
    Calses, Philamer C.
    Crawford, James J.
    Lill, Jennie R.
    Dey, Anwesha
    TRENDS IN CANCER, 2019, 5 (05): : 297 - 307